Authors: JOSTING A KATAY I RUEFFER U WINTER S TESCH H ENGERT A DIEHL V WICKRAMANAYAKE PD

Citation: A. Josting et al., FAVORABLE OUTCOME OF PATIENTS WITH RELAPSED OR REFRACTORY HODGKINS-DISEASE TREATED WITH HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE AT THE TIME OF MAXIMAL RESPONSE TO CONVENTIONAL SALVAGE THERAPY (DEXA-BEAM), Annals of oncology, 9(3), 1998, pp. 289-295

Authors: WICKRAMANAYAKE PD KATAY I JOSTING A DIEHL V

Citation: Pd. Wickramanayake et al., SYSTEMIC ADJUVANT THERAPY FOR BREAST-CANC ER, Medizinische Klinik, 91(10), 1996, pp. 646-653

Authors: JOSTING A RUFFER U KATAY I SCHULZ A SCHEID C DIEHL V WICKRAMANAYKE PD

Citation: A. Josting et al., DEXA-BEAM CHEMOTHERAPY IN RELAPSED OR RESISTANT NON-HODGKINS-LYMPHOMA- A PILOT-STUDY, Onkologie, 18(3), 1995, pp. 246-250

Authors: WICKRAMANAYAKE PD STEINMETZ HT KATAY I GLASMACHER A STAIB P DIEHL V

Citation: Pd. Wickramanayake et al., PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, ARA-C, AND FILGRASTIM FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 3009-3009

Authors: SCHEID C FUCHS M WINTER S SCHULZ A JOSTING A KATAY I DIEHL V DIASWICKRAMANAYAKE P

Citation: C. Scheid et al., DIFFERENTIATION OF A CELL-LINE FROM A PATIENT WITH ACUTE MEGAKARYOBLASTIC LEUKEMIA AWL M7, Blood, 86(10), 1995, pp. 3100-3100

Authors: WICKRAMANAVAKE PD STEINMETZ HT KATAY I GLASMACHER A NEUFANG A STAIB P SCHWONZEN M DIEHL V

Citation: Pd. Wickramanavake et al., PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, CYTIDINE ARABINOSIDE (ARA-C), AND FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000618-10000618